EGeen International's Series A Round

EGeen International raised a round of funding on November 11, 2002.

EGeen International is a privately held emerging biotechnology company focused on drug and diagnostic target discovery, and personalized medicine applications. EGeen has exclusive commercial rights to…

Articles about EGeen International's Series A Round: